Skip to content

Insider · CIK 0001853903

Allison David D.

Reports to the SEC for 2 companies · SEATTLE, WA

Transactions

16

Companies

2

Filings

10

CIK

0001853903

Forms 4 and 5

Insider transactions

16 trades
DateCompanyValue
2024-04-05IPI Legacy Liquidation CoStock Option (right to buy)J Other—
2024-04-05IPI Legacy Liquidation CoStock Option (right to buy)J Other—
2024-04-05IPI Legacy Liquidation CoStock Option (right to buy)J Other—
2023-06-16IPI Legacy Liquidation CoStock Option (right to buy)A Award—
2023-02-24CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2023-02-24CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2023-02-24CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2023-02-24CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2023-02-24CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2023-01-06CinCor Pharma, Inc.Stock Option (Right to Buy)A Award+$12.5K
2022-10-07CinCor Pharma, Inc.Stock Option (Right to Buy)A Award+$12.5K
2022-07-08CinCor Pharma, Inc.Stock Option (Right to Buy)A Award+$12.5K
2022-06-16IPI Legacy Liquidation CoStock Option (right to buy)A Award—
2022-04-08CinCor Pharma, Inc.Stock Option (Right to Buy)A Award+$12.5K
2022-04-08CinCor Pharma, Inc.Stock Option (Right to Buy)A Award—
2021-07-11IPI Legacy Liquidation CoStock Option (right to buy)A Award—

Recent filings

10

Companies

2

Address

C/O IMPEL NEUROPHARMA, INC. 201 ELLIOTT AVE. W, ST. 260

SEATTLE, WA, 98119